@dansfera: The clinical trial industry has a major transparency problem, and this experiment proves it. A tech vendor decided to go undercover as a study participant, only to be met with a frustrating brick wall: being forced into an in-person pre-screening just to get basic information. The resulting debate on LinkedIn is exposing a deep divide in the industry—some sites argue that in-person visits are the only way to filter out no-shows and save time, while others see it as a massive barrier to patient access. Is this broken process protecting resources, or is it just killing recruitment numbers? #ClinicalTrials #PharmaTech #PatientRecruitment #HealthcareInnovation #MedTwitter